Evaluation of Therapeutic Adherence Among Patients Followed in the Department of Hereditary Metabolic Diseases at Necker Hospital

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age7-20
SponsorAssistance Publique - Hôpitaux de Paris

About this trial

The purpose of this study is to evaluate treatment adherence among patients followed in the Department of Inherited Metabolic Diseases at Necker Hospital, in order to assess the need for implementing a therapeutic education workshop focused on medication adherence.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

All patients followed in the Hereditary Metabolic Diseases department of Necker Hospital during their visit to the department for their usual care and having a specific daily oral medication treatment.

Children aged at least 7 years and adolescents/young adults

Holders of parental authority and children or adolescents or adults' patients informed and consenting to participate in the study

Disqualifiers

Metabolic disease without oral medication (intravenous treatments, amino acid mixtures, and dietary regimens are not evaluated).

Patient and parents not proficient in French.

Refusal by the patient's holders of parental authority or adult patient to participate in the study and/or refusal of the child/adolescent.

Trial population

Patients followed in the department of hereditary metabolic diseases at Necker Hospital, having specific oral drug treatment, and having a scheduled care appointment at Necker Hospital as part of their usual follow-up, during the study inclusion period.

Trial design

Design model

Case-only

Time perspective

Prospective

Treatments tested in this trial

  • Questionnaire

    Other intervention

    A pseudonymized questionnaire assessing treatment adherence, understanding of the illness, knowledge of medications, and the number of oral medications taken is given to patients and/or their parents during a follow-up visit, whether in a consultation, day hospital, or conventional hospitalization. It is completed by parents and children aged 7 and older, as well as by adolescents and young adults. The responses will not be disclosed to the physicians in the department.

  • Calculation of the metabolic balance score

    Other intervention

    For patients with urea cycle deficiency, a metabolic balance score will be calculated independently from retrospective data from the medical record, in the last two years preceding the completion of the questionnaire.

Treatment groups

200 Participants
are divided into 1 treatment group
Group A: Patients2 interventions

Trial outcomes

Primary outcomes

1

Assessment of therapeutic adherence

Therapeutic adherence score, established from the declarations of patients and their parents to the study questionnaire.

Time frame
Time 0

Secondary outcomes

1

Number of treatments taken each day

Quantification of the number of medications taken daily based on the declarations of patients and their parents to the study questionnaire.

Time frame
Time 0
2

Knowledge of the disease

Assessment of patients' and their parents' knowledge of the disease establish from the declarations of patients and their parents to the study questionnaire.

Time frame
Time 0
3

Knowledge of treatments

Accordance of patients' and their parents' knowledge of treatments, based on the declarations of patients and their parents in the study questionnaire and the patient's prescriptions in the medical record.

Time frame
Time 0
4

Correlation between the therapeutic adherence score and the number of medications taken daily by patients

The therapeutic adherence score and the number of medications taken daily are established from the declarations of patients and their parents to the study questionnaire.

Time frame
Time 0

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Assistance Publique - Hôpitaux de Paris

Lead sponsor

URC-CIC Paris Descartes Necker Cochin

Collaborator